A meta-analysis of individual patient data from 12 randomized trials including 15,457 patients. Presented as SABCS 2019.
We are delighted to inform you that the long-term follow-up results of the randomized IIBIS-II trial have been published in Lancet.
Results of a protocol-predefined secondary analysis from PANTHER trial have been published in Cancer.
ESMO Breast Cancer 2020 will take place on 7-9 May 2020 in Berlin, Germany.
A translational study evaluating the role of tumor immunogenicity in patients from GeparTrio trial has been published in Breast Cancer Research.
GBG Forschungs GmbHMartin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440
+49 6102 7480-0 | nfGBGd